Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Takeda’s Entyvio Bests Humira in Head-to-Head UC Study
BioSpace
Mon, 03/11/19 - 10:25 am
Tags:
Takeda, Entyvio, AbbVie, Humira, ulcerative colitis
Two big pharma execs share the same challenges, but compensation? They’re not even close
Endpoints
Mon, 03/11/19 - 10:04 am
Tags:
Pharma CEOs, executive pay, AbbVie, Sanofi, Richard Gonzalez, Olivier Brandicourt
Louisiana's 'Netflix' deal for hepatitis C drugs wins bids from AbbVie, Gilead and Merck
Fierce Pharma
Thu, 03/7/19 - 09:19 pm
Tags:
hepatitis C, AbbVie, Gilead Sciences, Louisiana, Netflix model
Synlogic Achieves Milestone in Development of Synthetic Biotic for IBD
CP Wire
Thu, 03/7/19 - 10:28 am
Tags:
Synlogic, inflammatory bowel disease, AbbVie
Thu, 03/7/19 - 10:05 am
Tags:
Synlogic, inflammatory bowel disease, AbbVie
Genentech Submits sNDA For Venclexta and Gazyva Combo for Chronic Lymphocytic Leukemia
CP Wire
Thu, 03/7/19 - 09:53 am
Tags:
Genentech, Roche, AbbVie, chronic lymphocytic leukemia, Gazyva, Venclexta
Thu, 03/7/19 - 09:35 am
Tags:
Genentech, Roche, AbbVie, chronic lymphocytic leukemia, Gazyva, Venclexta
AbbVie and Pfizer return to the top of pharma's TV spending list for February
Fierce Pharma
Wed, 03/6/19 - 11:36 am
Tags:
AbbVie, Humira, Pfizer, Xeljanz, television ads, DTC ads
AbbVie, Akcea benefit from latest CHMP recommendations
Biopharma Dive
Sun, 03/3/19 - 07:12 pm
Tags:
Europe, CHMP, AbbVie, Akcea, Biomarin, Sanofi, Pfizer, drug approvals
Hand over your Humira biosim launch plans; judge tells Boehringer in AbbVie patent fight
Fierce Pharma
Wed, 02/27/19 - 12:06 pm
Tags:
AbbVie, Boehringer Ingelheim, Humira, biosimilars
Why Abbvie May Have A Tough Time Defending Humira's Price Before Congress
Forbes
Tue, 02/26/19 - 09:35 am
Tags:
AbbVie, Humira, drug pricing, Senate, pharma executives
AbbVie’s cancer drug Venclexta blocks diabetes in mice by targeting beta cell ‘senescence’
Fierce Biotech
Fri, 02/22/19 - 11:50 am
Tags:
senescence, Venclexta, type 1 diabetes, AbbVie
Voyager Shares Take Off on Parkinson's Disease Development Deal
TheStreet.com
Fri, 02/22/19 - 10:11 am
Tags:
Voyager Therapeutics, gene therapy, AbbVie, Parkinson's Disease
The fighter, the saint, and the odd man out: the executives who will defend pharma before Congress
Stat
Thu, 02/21/19 - 12:41 pm
Tags:
drug pricing, US Congress, Donald Trump, Richard Gonzalez, AbbVie, Ken Frazier, Merck, JNJ, Jennifer Taubert, Olivier Brandicourt, Sanofi, Pascal Soriot, AstraZeneca, Giovanni Caforio, Bristol-Myers Squibb, Albert Bourla, Pfizer
Morphic bags J&J as second big pharma partner for oral integrins
Fierce Biotech
Thu, 02/21/19 - 10:26 am
Tags:
JNJ, AbbVie, Morphic Therapeutic, small-molecule integrins
AbbVie’s JAK inhibitor upadacitinib gets Priority Review
Pharmaforum
Wed, 02/20/19 - 11:23 am
Tags:
AbbVie, upadacatinib, FDA, priority review, rheumatoid arthritis, Humira
2 Pharma Stocks in the Middle of an Oncology Sales Explosion
Motley Fool
Tue, 02/19/19 - 08:01 pm
Tags:
oncology, Roche, AbbVie, AstraZeneca
Hurricanes, droughts, and wildfires: How biopharma is girding for climate change
Stat
Fri, 02/15/19 - 10:29 am
Tags:
climate change, natural disasters, tropical diseases, Takeda, AbbVie, Roche
AbbVie gains option to Teneobio BCMA program
BioCentury
Mon, 02/11/19 - 08:04 pm
Tags:
AbbVie, Teneobio, TNB-383B, Multiple Myeloma
AbbVie loses bid to hoard documents in Humira patent fight with Boehringer
Fierce Pharma
Mon, 02/11/19 - 12:21 pm
Tags:
Boehringer Ingelheim, AbbVie, biosimilars, Humira, patents

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.